What conditions is Spravato approved to treat in Delray Beach?
Spravato is an FDA-approved prescription nasal spray used in conjunction with an oral antidepressant. It is specifically indicated for adults with treatment-resistant depression and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not approved for conditions like PTSD or chronic pain.
Can I drive home after a ketamine infusion in Palm Beach County?
No. Whether you receive an off-label ketamine infusion or FDA-approved Spravato, the medication can cause sedation and dissociation. Clinical protocols require that you do not drive or operate heavy machinery until the following day, after you have had a restful sleep. A responsible adult must drive you home.
Are there ketamine clinics physically located in Delray Beach?
While there may be medical providers in Delray Beach, our directory highlights regional options such as K\MD Wellness in Boca Raton and Hope Accelerated Care in West Palm Beach. Patients often travel within Palm Beach County to find a clinic that meets their specific psychiatric and logistical needs.
Will my insurance cover off-label ketamine infusions in South Florida?
Intravenous (IV), intramuscular (IM), and sublingual ketamine are used off-label for mental health conditions and are generally not covered by standard health insurance plans. Patients typically pay out-of-pocket for these services. It is advisable to request a detailed, written estimate of all costs before beginning your treatment program.
How does hurricane season affect ketamine therapy scheduling?
Ketamine therapy requires a strict schedule of repeated visits, especially during the initial induction phase. In South Florida, severe weather during hurricane season can cause clinic closures or make travel unsafe. Patients should discuss contingency plans with their provider to ensure continuity of care during weather emergencies.
Is it safe to take compounded ketamine at home?
Compounded ketamine prescribed for home use is not FDA-approved for psychiatric care. The FDA has issued warnings regarding the potential risks of using these products without direct, on-site medical monitoring. Spravato, the only FDA-approved ketamine-derived medication for depression, is strictly administered in certified healthcare settings, never at home.